2024 NOSCM | Antibody Drug Conjugates for HER2 Negative Breast Cancer: A Revolution in Chemotherapy for Breast Cancer
Overview
NA
Target Audience
NA
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Hope S. Rugo, MD, FASCO
Date of Release
May 14th, 2025
-1750785566843.webp&w=3840&q=75)
